Zynex, Inc. (ZYXI)
NASDAQ: ZYXI · IEX Real-Time Price · USD
11.00
-0.54 (-4.68%)
At close: May 3, 2024, 4:00 PM
10.51
-0.49 (-4.45%)
After-hours: May 3, 2024, 7:30 PM EDT

Zynex Revenue

Zynex had revenue of $188.68M in the twelve months ending March 31, 2024, with 11.48% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $46.53M with 10.34% year-over-year growth. In the year 2023, Zynex had annual revenue of $184.32M with 16.54% growth.

Revenue (ttm)
$188.68M
Revenue Growth
+11.48%
P/S Ratio
1.85
Revenue / Employee
$171,530
Employees
1,100
Market Cap
349.53M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023184.32M26.16M16.54%
Dec 31, 2022158.17M27.87M21.39%
Dec 31, 2021130.30M50.18M62.63%
Dec 31, 202080.12M34.65M76.20%
Dec 31, 201945.47M13.56M42.47%
Dec 31, 201831.92M8.49M36.21%
Dec 31, 201723.43M10.12M76.01%
Dec 31, 201613.31M1.67M14.36%
Dec 31, 201511.64M524.00K4.71%
Dec 31, 201411.12M-10.57M-48.73%
Dec 31, 201321.68M-25.47M-54.01%
Dec 31, 201247.15M7.48M18.84%
Dec 31, 201139.68M11.19M39.29%
Dec 31, 201028.49M7.58M36.23%
Dec 31, 200920.91M7.64M57.62%
Dec 31, 200813.27M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
DocGo 624.29M
Health Catalyst 295.94M
Amarin Corporation 277.46M
Harrow Health 130.19M
Pulmonx 68.68M
Contineum Therapeutics 50.00M
TScan Therapeutics 21.05M
Atai Life Sciences 314.00K
Revenue Rankings